Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Desmoid tumors.

J S Biermann1

  • 1Orthopaedic Surgery, University of Michigan, 1500 E Medical Center Drive, 7304 CCGC, Ann Arbor, MI, 48109-0946, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary
This summary is machine-generated.

Treatment for desmoid tumors is individualized due to varied locations and patient factors. Optimal management requires a multidisciplinary approach, often involving surgery, radiation, or chemotherapy, depending on the specific case.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of advanced metastatic lesions of the acetabulum using the saddle prosthesis.

Clinical orthopaedics and related research·2004
Same author

The recruitment of women in orthopaedic surgery.

The Journal of bone and joint surgery. American volume·2001
Same author

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Same author

Evaluation of cancer information on the Internet.

Cancer·1999
Same author

Soft tissue sarcoma: opening the door to advances in diagnosis and treatment.

Cancer·1999
Same author

Sarcoidosis presenting as a tumorlike muscular lesion. Case report and review of the literature.

Medicine·1999
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Surgical Pathology
  • Radiology

Background:

  • Desmoid tumors present diverse clinical challenges due to varied anatomic locations and patient-specific factors.
  • No single treatment modality guarantees remission, necessitating tailored therapeutic strategies.
  • While mortality is rare, desmoid tumors can cause significant morbidity and disability.

Purpose of the Study:

  • To outline the complexities in managing desmoid tumors.
  • To emphasize the need for individualized treatment plans.
  • To highlight the importance of a multidisciplinary approach in patient care.

Main Methods:

  • Review of current treatment modalities for desmoid tumors.
  • Consideration of tumor and patient characteristics in treatment selection.

Related Experiment Videos

  • Evaluation of multidisciplinary team collaboration in optimal patient management.

    • Main Results:

    • Treatment selection is contingent upon tumor characteristics, location, and patient preferences.
    • Surgical resection with negative margins is preferred when feasible and not disabling.
    • Observation is a viable option for specific tumor presentations, including FAP-associated mesenteric lesions.

    Conclusions:

    • Individualized treatment plans are crucial for desmoid tumors.
    • Multidisciplinary management optimizes patient outcomes.
    • Alternative therapies like radiation, hormonal therapy, or chemotherapy are considered when surgery is not ideal.